The IL-33/ST2 axis promotes the development of primary Sjogren’s syndrome by activating salivary epithelial cells and the type 1 immune response in a mouse model of experimental Sjogren’s syndrome [185]. Here, IL1RL1 is linked to Sjogren syndrome.